Weekly Newsletter

How Tools like eCaps and Fitbits are making Clinical Studies more Accurate and Inclusive ?

Sarah, a researcher uses the eCAP smart pill bottle to track medication habits accurately, without relying on participants' memory. Her colleague Tom uses adaptive trial designs and digital devices like Fitbits to collect real-time health data, personalizing treatments for better outcomes.

The Role of AI in Clinical Trials: Insights from Industry Experts

AI has the potential to significantly enhance clinical trials by speeding up research and substantially reducing duration. Companies interested in adopting the technology focus on finding seamless ways to integrate it into their operational processes and, more importantly, identifying cases with the highest ROI.

Data-Driven Development: How Real-World Data and AI Are Transforming Clinical Trials ?

AI technology could be revolutionary for clinical trials, helping vastly reduce the cost of certain trial elements or even whole phases.?A 2020 study found that a pivotal phase 3 trial across therapeutic areas costs an average of $19 million, compared to the average cost of RWD and AI analyses, which range in price from $150,000 to just over $1 million.

Data-Driven Devices: Powering Healthcare's Digital Revolution ?

The synergy between data-driven devices and home-based care models is setting the stage for a healthcare revolution. Remote monitoring and AI-enhanced diagnostics are creating "home hospitals" that prioritize patient-centered care, improving both the experience and cost-effectiveness of treatment. Additionally, the proliferation of data collection through wearables and other technologies fosters patient engagement and self-management.